Optimiser la vaccination contre l’influenza chez les adultes de 65 ans et plus : choisir le bon vaccin pour une protection accrue
This program discusses the increased risk of severe influenza complications for adults aged 65 and over due to immunosenescence and comorbidities, highlighting the benefits of high-dose flu vaccines. It also provides current recommendations and practical strategies to improve vaccination coverage.
- The description claims that high-dose flu vaccines offer the best protection against hospitalizations and associated complications.
AI Readiness
Good foundation, but some important product data is still missing.
53%